Dimensional Fund Advisors
HARP

Dimensional Fund Advisors’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Dimensional Fund Advisors’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$66K Sell
6,812
-1,611
-19% -$30.1K ﹤0.01% 3376
2022
Q2 		$161K Sell
8,423
-1,904
-18% -$49.3K ﹤0.01% 3275
2022
Q1 		$513K Buy
10,327
+3,458
+50% +$179K ﹤0.01% 3142
2021
Q4 		$519K Buy
6,869
+82
+1% +$5.6K ﹤0.01% 3158
2021
Q3 		$536K Sell
6,787
-2,661
-28% -$267K ﹤0.01% 3164
2021
Q2 		$1.31M Buy
9,448
+6,509
+221% +$1.24M ﹤0.01% 2977
2021
Q1 		$615K Sell
2,939
-130
-4% -$26.1K ﹤0.01% 3103
2020
Q4 		$510K Sell
3,069
-69
-2% -$10.7K ﹤0.01% 3091
2020
Q3 		$532K Buy
3,138
+1,002
+47% +$145K ﹤0.01% 3046
2020
Q2 		$354K Buy
+2,136
New +$333K ﹤0.01% 3135

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors's HARP Position: Q3 2022 in Review

Dimensional Fund Advisors reduced its Harpoon Therapeutics, Inc. Common Stock (HARP) stake by 19% in Q3 2022, selling an estimated $30.1K and leaving 6,812 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #3376.

Dimensional Fund Advisors first reported a position in HARP in Q2 2020 and has held it in 10 quarters since. The position peaked at $1.31M in Q2 2021. 52 funds tracked by Wall St. Rank hold HARP as of Q3 2022.

  • Dimensional Fund Advisors held 6,812 shares of Harpoon Therapeutics, Inc. Common Stock worth $66K as of Q3 2022.
  • Dimensional Fund Advisors sold 1,611 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $30.1K.
  • Harpoon Therapeutics, Inc. Common Stock made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3376 holding.
  • Dimensional Fund Advisors first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2020 and has held it in 10 quarters since.
  • Dimensional Fund Advisors's Harpoon Therapeutics, Inc. Common Stock position peaked at $1.31M in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.